# Phase 1 Dose Escalation Study of MEDI-565, a Bispecific T-Cell Engager that Targets Human Carcinoembryonic Antigen, in Patients With Advanced Gastrointestinal Adenocarcinomas

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-1-dose-escalation-study-of-medi-565-a-bispecific-t-cell-engager-that/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Michael J. Pishvaian,Michael A. Morse,Jennifer McDevitt,Jonathan Norton,Song Ren,Gabriel J. Robbie,Patricia C. Ryan,Serguei Soukharev,Haifeng Bao,Crystal S. Denlinger |
| Citations | 96 |
| DOI | 10.1016/j.clcc.2016.07.009 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2484886006 |
| PMID | 27591895 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Song Ren](https://scholariq.org/researchers/song-ren/)

## Paper primary topic

- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)

## Paper topics

- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Radiopharmaceutical Chemistry and Applications](https://scholariq.org/topics/radiopharmaceutical-chemistry-and-applications/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.